Fighting Lupus

MIT's Technology Review reports on a new approach to treating lupus that could reverse the autoimmune disease's effects on the immune system. Two companies — ImmuPharma in London and Cephalon in Pennsylvania — are collaborating to develop an experimental drug called Lupuzor, which has just ended Phase II trials with some promising data, the Review's Arlene Weintraub says. Instead of shutting down the immune system the way chemotherapy does, Lupuzor targets T and B cells.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.